Author

Sedat Biter

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

EZH2 expression in diffuse large B-cell lymphoma: clinicopathological associations and relationship with survival

Purpose: Enhancer of zeste homolog 2 (EZH2) is an epigenetic regulator implicated in the pathogenesis of diffuse large B-cell lymphoma, but the prognostic value of its protein expression is uncertain. We evaluated EZH2 expression and its associations with clinicopathological features and survival.Materials and Methods:...

Mehmet Mutlu Kıdı, Mehmet Turker, Sedat Biter et al. · Cukurova Medical Journal · 0 citations

Open access Sep 2026

Prognostic Value of Pretreatment Modified Glasgow Prognostic Score in Nivolumab-Treated Advanced Non-Small Cell Lung Cancer

Background/Objectives: Immune checkpoint inhibitors have become a standard treatment option for advanced/metastatic non-small cell lung cancer (NSCLC); however, considerable heterogeneity exists among patients regarding treatment response and survival. This study aimed to determine whether the pretreatment modified Gla...

Sedat Biter, Mehmet Mutlu Kıdı, Yasemin Aydınalp Camadan et al. · Journal of Clinical Medicine · 0 citations

Review Open access Sep 2026

Clinicopathological Features, Treatment Modalities, and Prognostic Factors of Leptomeningeal Carcinomatosis in Patients with Breast Cancer: A Single-Center Retrospective Analysis

Aim: Leptomeningeal metastasis (LM) from breast cancer carries a poor prognosis, and most published cohorts originate from high-volume referral centers. We aimed to identify factors associated with overall survival (OS) after an LM diagnosis in routine practice and to describe diagnostic and treatment patterns.Methods:...

Mehmet Mutlu Kıdı, Omer Kaya, Sedat Biter et al. · Cukurova Anestezi ve Cerrahi... · 0 citations